Engineering bacteria and bionic bacterial derivatives with nanoparticles for cancer therapy

T Yin, Z Diao, NT Blum, L Qiu, A Ma, P Huang - Small, 2022 - Wiley Online Library
Natural bacteria are interesting subjects for cancer treatments owing to their unique
autonomy‐driven and hypoxic target properties. Genetically modified bacteria (such as …

Vaccines against invasive Salmonella disease: Current status and future directions

CA MacLennan, LB Martin, F Micoli - Human vaccines & …, 2014 - Taylor & Francis
Though primarily enteric pathogens, Salmonellae are responsible for a considerable yet
under-appreciated global burden of invasive disease. In South and South-East Asia, this …

Recoded organisms engineered to depend on synthetic amino acids

AJ Rovner, AD Haimovich, SR Katz, Z Li, MW Grome… - Nature, 2015 - nature.com
Genetically modified organisms (GMOs) are increasingly used in research and industrial
systems to produce high-value pharmaceuticals, fuels and chemicals. Genetic isolation and …

Bacteria in cancer therapy: renaissance of an old concept

S Felgner, D Kocijancic, M Frahm… - International journal of …, 2016 - Wiley Online Library
The rising incidence of cancer cases worldwide generates an urgent need of novel
treatment options. Applying bacteria may represent a valuable therapeutic variant that is …

Genetically engineered Salmonella Typhimurium: Recent advances in cancer therapy

K Liang, Q Liu, P Li, H Luo, H Wang, Q Kong - Cancer letters, 2019 - Elsevier
Bacteria have been investigated as anti-tumor therapeutic agents for more than a century,
since Coley first observed successful curing of a patient with inoperable cancer by injection …

[HTML][HTML] Rational design of evolutionarily stable microbial kill switches

F Stirling, L Bitzan, S O'Keefe, E Redfield, JWK Oliver… - Molecular cell, 2017 - cell.com
The evolutionary stability of synthetic genetic circuits is key to both the understanding and
application of genetic control elements. One useful but challenging situation is a switch …

[HTML][HTML] Targeted DNA degradation using a CRISPR device stably carried in the host genome

BJ Caliando, CA Voigt - Nature communications, 2015 - nature.com
Once an engineered organism completes its task, it is useful to degrade the associated DNA
to reduce environmental release and protect intellectual property. Here we present a …

Synthetic microbes as drug delivery systems

J Claesen, MA Fischbach - ACS synthetic biology, 2015 - ACS Publications
Synthetic cell therapy is a field that has broad potential for future applications in human
disease treatment. Next generation therapies will consist of engineered bacterial strains …

Multilayered genetic safeguards limit growth of microorganisms to defined environments

RR Gallagher, JR Patel, AL Interiano… - Nucleic acids …, 2015 - academic.oup.com
Genetically modified organisms (GMOs) are commonly used to produce valuable
compounds in closed industrial systems. However, their emerging applications in open …

Precision design of stable genetic circuits carried in highly‐insulated E. coli genomic landing pads

Y Park, A Espah Borujeni, TE Gorochowski… - Molecular systems …, 2020 - embopress.org
Genetic circuits have many applications, from guiding living therapeutics to ordering process
in a bioreactor, but to be useful they have to be genetically stable and not hinder the host …